aristolochic acid i has been researched along with folic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamowicz, K; Foresto-Neto, O; Honarpisheh, M; Koehler, P; Koziel, J; Kraft, F; Lech, M; Potempa, J; Steiger, S; von Rauchhaupt, E | 1 |
| Fu, P; Guo, F; Huang, R; Li, L; Liu, J; Ma, L; Tan, Z; Tao, S; Zeng, X | 1 |
2 other study(ies) available for aristolochic acid i and folic acid
| Article | Year |
|---|---|
Aristolochic acid I determine the phenotype and activation of macrophages in acute and chronic kidney disease.
Topics: Acute Kidney Injury; Animals; Aristolochic Acids; Cisplatin; Disease Models, Animal; Female; Fibrosis; Folic Acid; Kidney; Kidney Diseases; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Phenotype; Renal Insufficiency, Chronic | 2018 |
Genetic and pharmacological inhibition of fatty acid-binding protein 4 alleviated inflammation and early fibrosis after toxin induced kidney injury.
Topics: Acute Kidney Injury; Animals; Aristolochic Acids; Biphenyl Compounds; Carcinogens; Disease Models, Animal; Fatty Acid-Binding Proteins; Fibrosis; Folic Acid; Hematinics; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyrazoles; RNA, Small Interfering | 2021 |